Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03867227Completed

Non-pharmacological Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation

Role: collaborator

NCT04657705Not ApplicableCompleted

Application of High Power Radio Frequency Energy in the Ventricular Tachycardia Treatment

Role: collaborator

NCT03857711Not ApplicableUnknown

Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation)

Role: lead

NCT04237389Not ApplicableUnknown

Thoracoscopic Ablation Versus Catheter Ablation in Patients With Atrial Fibrillation

Role: lead

NCT03909581Not ApplicableUnknown

EndoACAB vs PCI for LAD Revascularization

Role: lead

All 5 trials loaded